SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $72.96 | 52-week high | $92.60 |
Prev. close | $73.70 | 52-week low | $72.44 |
Day low | $72.81 | Volume | 10,312,900 |
Day high | $74.22 | Avg. volume | 7,817,006 |
50-day MA | $79.99 | Dividend yield | N/A |
200-day MA | $82.28 |
XBI Stock Price Chart Interactive Chart >
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
Issuer | State Street Global Advisors |
Expense Ratio | 0.35% |
Underlying Index | S&P Biotechnology Select Industry Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 5.65B |
Net Asset Value (NAV) | $73.68 |
Options? | Yes |
Total Holdings | 139 |
XBI Top Holdings
Symbol | Company | % of Total |
APLS | APELLIS PHARMACEUTICALS INC | 1.49% |
NBIX | NEUROCRINE BIOSCIENCES INC | 1.33% |
AMGN | AMGEN INC | 1.33% |
ALKS | ALKERMES PLC | 1.33% |
IONS | IONIS PHARMACEUTICALS INC | 1.31% |
ABBV | ABBVIE INC | 1.31% |
HALO | HALOZYME THERAPEUTICS INC | 1.31% |
VRTX | VERTEX PHARMACEUTICALS INC | 1.31% |
SGEN | SEAGEN INC | 1.29% |
RXRX | RECURSION PHARMACEUTICALS A | 1.28% |
XBI Price Returns
1-mo | -6.25% |
3-mo | -14.29% |
6-mo | -2.65% |
1-year | -4.81% |
3-year | -33.06% |
5-year | -24.29% |
YTD | -12.09% |
2022 | -25.87% |
2021 | -20.45% |
2020 | 48.33% |
2019 | 32.56% |
2018 | -15.28% |